Details of the Drug Reposition

General Information of This Drug (ID: DM61TA4)

Drug Name
Arsenic trioxide   DM61TA4
Synonyms
Arsenox; Arsentrioxide; Naonobin; Trisenox; Trixenox; Acide arsenieux [French]; Anhydride arsenieux [French]; Arseni trioxydum; Arsenic blanc [French]; Arsenic trioxide [JAN]; Arsenigen saure [German]; Arsenious Acid Anhydride; Arsenious trioxide; Arsenous oxide [ISO]; Oxyde Arsenieux; Arsenic trioxide [UN1561] [Poison]; Arsenic oxide (As2O3); Arsenic(III) trioxide; Oxyde Arsenieux [ISO-French]; Trisenox (TN); Arsenic trioxide (JP15/USAN); Arsenic(3+)
Therapeutic Class
Anticancer Agents
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
2 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Refractory plasma cell neoplasm DIS78CK0 N.A. Approved [1]
Leukemia DISNAKFL N.A. Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 3 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Esophageal adenocarcinoma DISODWFP N.A. Discontinued in Phase 3 [2]
------------------------------------------------------------------------------------
4 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Acute myelomonocytic leukemia M4 DISRRMV2 N.A. Discontinued in Phase 2 [3]
Myelodysplastic syndrome DISYHNUI 2A37 Discontinued in Phase 2 [4]
Promyelocytic leukaemia DISYGG13 2A82.1 Discontinued in Phase 2 [5]
Acute lymphocytic leukaemia DISPX75S 2B33.3 Discontinued in Phase 2 [6]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Endometrial carcinoma DISXR5CY N.A. Investigative [1]
------------------------------------------------------------------------------------

References

1 Arsenic trioxide FDA Label
2 Tamsulosin for Urinary Retention in Hospitalized Older Women
3 Therapeutic Allogeneic Lymphocytes and Aldesleukin in Treating Patients With High-Risk or Recurrent Myeloid Leukemia After Undergoing Donor Stem Cell Transplant
4 Use of Maytenus Ilicifolia in the Treatment of Dyspepsia
5 Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
6 Finasteride for Chronic Central Serous Chorioretinopathy